Completed NA INTERVENTIONAL 2-arm NCT02088567

Amniotic Membrane in Total Knee Replacements to Reduce Scarring

A Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane (dHACM) in Total Knee Replacement Patients to Reduce Post-operative Scarring.

Sponsor: MiMedx Group, Inc.

Conditions Scarring

Interventions Application of dHACM Total Knee Arthroplasty

Updated 5 times since 2017 Last updated: Sep 21, 2015 Started: Jan 31, 2014 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Scarring and is currently completed. MiMedx Group, Inc. leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MiMedx Group, Inc.

Data source: MiMedx Group, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Decatur, United States